Form 13-F position report

CORBUS PHARMACEUTICALS HLDG

Reported by CHARLES SCHWAB INVESTMENT MANAGEMENT INC

CRBP CUSIP 21833P103 Manager CIK 0000884546

Reported 0 shares, down 99,416 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q1 2023
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 24 Through Q1 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 28000
2022-03-31 0
2022-06-30 26000
2022-09-30 17000
2022-12-31 10985
2023-03-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

6 quarters
Quarterly reported position history for CORBUS PHARMACEUTICALS HLDG held by CHARLES SCHWAB INVESTMENT MANAGEMENT INC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q1 2023 Reduced 0 -99,416 (-100.0%) 0 $0 2023-05-12
Q4 2022 Unchanged 99,416 0 (0.0%) < 0.01% $10,985 2023-02-13
Q3 2022 Unchanged 99,416 0 (0.0%) < 0.01% $17,000 2022-11-14
Q2 2022 New 99,416 +99,416 (0.0%) < 0.01% $26,000 2022-08-15
Q1 2022 Reduced 0 -44,959 (-100.0%) 0 $0 2022-05-13
Q4 2021 Unchanged 44,959 0 (0.0%) < 0.01% $28,000 2022-02-11
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

63 managers reported CORBUS PHARMACEUTICALS HLDG for Q1 2023.

Managers reporting CORBUS PHARMACEUTICALS HLDG in Q1 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
IFP Advisors Inc Added 100 +86 < 0.01% $595 5 qtrs
MORGAN STANLEY Reduced 0 -83,430 0 $0 32 qtrs
Aries Wealth Management Reduced 0 -15,400 0 $0 22 qtrs
TWO SIGMA SECURITIES LLC Reduced 0 -84,518 0 $0 8 qtrs
Accel Wealth Management Reduced 0 -1,383 0 $0 4 qtrs
HBK Sorce Advisory LLC Reduced 0 -13,750 0 $0 2 qtrs
TWO SIGMA INVESTMENTS LP Reduced 0 -570,168 0 $0 4 qtrs
ADVISOR GROUP HOLDINGS INC Reduced 0 -6,715 0 $0 13 qtrs
THE BANK OF NEW YORK MELLON CORPORATION Reduced 0 -32,061 0 $0 27 qtrs
HighTower Advisors LLC Reduced 0 -15,089 0 $0 10 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2023
Filed
May 12, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.